4//SEC Filing
Eisner Mark 4
Accession 0000950170-24-083951
CIK 0001706431other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:40 PM ET
Size
6.9 KB
Accession
0000950170-24-083951
Insider Transaction Report
Form 4
Eisner Mark
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2024-07-15+75,000→ 75,000 total - Award
Stock Option (Right to Buy)
2024-07-15+150,000→ 150,000 totalExercise: $9.37Exp: 2034-07-14→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on July 15, 2025, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001834161
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 4:40 PM ET
- Size
- 6.9 KB